Benefit of COLARIS® Testing

The results of the COLARIS® test enable the development of a patient-specific medical management roadmap to significantly reduce the risk of cancer.  COLARIS will help you to:

  • Target increased surveillance and other interventions specifically to individuals with a Lynch syndrome or MYH-associated polyposis mutation(s)€”maximizing patient care and increasing clinical efficiency
  • Improve patient compliance with tailored screening recommendations and preventive measures
  • Significantly improve outcomes and reduce medical costs through prevention, earlier diagnosis and treatment of cancer, should it develop
  • Counsel patients and family members on the underlying cause of cancer in their family
  • Avoid unnecessary interventions for family members who do not test positive for the mutation(s) known to be in the family

Medical Management Strategies that May Reduce the Risk of Cancer